As part of FSA’s head-to-head series, we compare the Fidelity Sustainable Healthcare fund and the Polar Capital Biotechnology fund.

As part of FSA’s head-to-head series, we compare the Fidelity Sustainable Healthcare fund and the Polar Capital Biotechnology fund.
Janus Henderson’s Andy Acker suggests the opportunity for healthcare outperformance is becoming more promising after last year’s difficulties.
Part of the Mark Allen Group.